GlassScriptPhysician profile
Arman Moshyedi
NPI 1649284209
$437.35
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $70.08 · 2021: $34.74 · 2022: $100.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $74.61 | 2019-2020 | |
| Inari Medical, INC. | $60.48 | 2020-2022 | |
| Cook Medical LLC | $48.86 | 2019-2022 | |
| Angiodynamics, INC. | $48.06 | 2019-2022 | |
| Boston Scientific Corporation | $39.90 | 2019-2022 | |
| Medtronic, INC. | $34.74 | 2021 | |
| Medtronic Vascular, INC. | $33.60 | 2019-2020 | |
| Ethicon US, LLC | $24.27 | 2019 | |
| Medtronic USA, INC. | $21.41 | 2019 | |
| Stryker Corporation | $20.76 | 2019 | |
| Abbott Laboratories | $15.94 | 2022 | |
| Covidien LP | $14.72 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arman Moshyedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.